Pharmacokinetics of Opicapone and Effect on COMT and Levodopa Pharmacokinetics in Patients with Parkinson's Disease

被引：0
|
作者：
Loewen, G. [1 ]
LeWitt, P. [2 ,3 ]
Olanow, C. W. [4 ]
Kieburtz, K. D. [5 ]
Liang, G. S. [1 ]
Jimenez, R. [1 ]
Olson, K. [1 ]
Roberts, E. [1 ]
机构：
[1] Neurocrine Biosci Inc, San Diego, CA USA
[2] Henry Ford Hosp, West Bloomfield, MI USA
[3] Wayne State Univ, Sch Med, Dept Neurol, West Bloomfield, MI USA
[4] Mt Sinai Sch Med, New York, NY USA
[5] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
18
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics of Opicapone and Effect on COMT and Levodopa Pharmacokinetics in Patients with Parkinson's Disease
    Loewen, G.
    LeWitt, P.
    Olanow, C.
    Kieburtz, K.
    Liang, G.
    Jimenez, R.
    Olson, K.
    Roberts, E.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S62 - S62
  • [2] Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease
    Ferreira, Joaquim J.
    Poewe, Werner
    Rascol, Olivier
    Stocchi, Fabrizio
    Antonini, Angelo
    Moreira, Joana
    Guimaraes, Bruno
    Rocha, Jose-Francisco
    Soares-da-Silva, Patricio
    [J]. MOVEMENT DISORDERS, 2022, 37 (11) : 2272 - 2283
  • [3] A Phase 1 Study of Opicapone Pharmacokinetics and Its Effects on COMT Activity and Levodopa Pharmacokinetics in Patients with Stable Parkinson's Disease
    Loewen, Gordon
    LeWitt, Peter
    Olanow, C. Warren
    Kieburtz, Karl D.
    Liang, Grace S.
    Jimenez, Roland
    Olson, Kurt
    Roberts, Eiry
    [J]. ANNALS OF NEUROLOGY, 2019, 86 : S180 - S180
  • [4] Levodopa Pharmacokinetics in Different Levodopa Treatment Regimens plus Opicapone in Parkinson's Disease
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Stocchi, F.
    Antonini, A.
    Moreira, J.
    Rocha, J.
    Soares-da-Silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 440 - 441
  • [5] Optimizing levodopa pharmacokinetics in Parkinson's disease: the role of COMT inhibitor
    Stocchi, F
    Vacca, L
    Grassini, P
    Battaglia, G
    Onofrj, M
    Valente, M
    Ruggieri, S
    [J]. NEUROLOGICAL SCIENCES, 2003, 24 (03) : 217 - 218
  • [6] Optimizing levodopa pharmacokinetics in Parkinson’s disease: the role of COMT inhibitor
    F. Stocchi
    L. Vacca
    P. Grassini
    G. Battaglia
    M. Onofrj
    M. Valente
    S. Ruggieri
    [J]. Neurological Sciences, 2003, 24 : 217 - 218
  • [7] Levodopa Pharmacokinetics in Different Levodopa Treatment Regimens plus Opicapone in Parkinson's Disease Patients with Motor Fluctuations
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Stocchi, F.
    Antonini, A.
    Moreira, J.
    Rocha, J. F.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S446 - S446
  • [8] Opicapone Pharmacokinetics and Effects on Catechol-O-Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa
    LeWitt, Peter
    Liang, Grace S.
    Olanow, C. Warren
    Kieburtz, Karl D.
    Jimenez, Roland
    Olson, Kurt
    Klepitskaya, Olga
    Loewen, Gordon
    [J]. CLINICAL NEUROPHARMACOLOGY, 2023, 46 (02) : 43 - 50
  • [9] Study design to assess the effect of opicapone on levodopa pharmacokinetics in different levodopa-optimized treatment regimens in Parkinson's disease patients
    Ferreira, Joaquim
    Poewe, Werner
    Rascol, Olivier
    Stocchi, Fabrizio
    Antonini, Angelo
    Moreira, Joana
    Rocha, Jose
    Soares-Da-Silva, Patricio
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 275 - 276
  • [10] Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease
    Ferreira, J. J.
    Rocha, J. -F.
    Falcao, A.
    Santos, A.
    Pinto, R.
    Nunes, T.
    Soares-da-Silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (05) : 815 - E56
12345